Business Context and Reporting Period
Chemed Corporation (CHEMED) filed a Form 8-K on April 10, 2026, reporting the renewal of its senior secured credit facilities. The company is incorporated in Delaware and maintains its principal executive offices in Cincinnati, Ohio.
Key Financial Metrics and Debt Structure
The filing details the terms of a renewed $450 million senior secured credit facility. Key components include:
- Total Facility Size: $450 million revolving credit facility.
- Letters of Credit: Up to $100 million available within the revolver.
- Term: Five-year duration.
- Interest Rate: Floating rate based on the Secured Overnight Financing Rate (SOFR) plus a tiered margin determined by the company's leverage ratio.
- Expansion Option: An accordion feature allowing an additional $250 million increase to the revolver.
- Administrative Agent: JPMorgan Chase Bank, N.A.
The filing does not provide specific values for revenue, profit, cash flow, operating margins, or current liquidity positions outside of the credit facility terms.
Material Changes
The primary material change is the execution of the Sixth Amended and Restated Credit Agreement on April 10, 2026, replacing the previous credit facility structure. This action creates a direct financial obligation under the new terms described above.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the facility renewal. The filing notes that the interest rate is variable and tied to the company's leverage ratio, implying that future interest expenses will fluctuate based on Chemed's debt levels. No specific forward-looking guidance, risk factors, or unusual items were disclosed in this specific report beyond the standard terms of the credit agreement.
Investor Verification Checklist
- Verify the current leverage ratio to determine the applicable interest rate margin under the new tiered structure.
- Review the full Sixth Amended and Restated Credit Agreement (Exhibit 10.1) for covenants and default provisions.
- Confirm the current utilization of the $450 million revolver and the $100 million letter of credit sub-limit.
- Assess the company's intent or likelihood of exercising the $250 million expansion feature.